Advertisement

Topics

MAXIMUS to Present at the Canaccord Genuity Growth Conference August 9

06:30 EDT 4 Aug 2017 | Businesswire
MAXIMUS

MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, announced today that Rick Nadeau, Chief Financial Officer, and Lisa Miles, Senior Vice President of Investor Relations & Corporate Communications, will present at the Canaccord Genuity Growth Conference on Wednesday, August 9 in Boston. The company will present at 11:00 a.m. ET.

About MAXIMUS

Since 1975, MAXIMUS has operated under its founding mission of Helping Government Serve the People®, enabling citizens around the globe to successfully engage with their governments at all levels and across a variety of health and human services programs. MAXIMUS delivers innovative business process management and technology solutions that contribute to improved outcomes for citizens and higher levels of productivity, accuracy, accountability and efficiency of government-sponsored programs. With more than 18,000 employees worldwide, MAXIMUS is a proud partner to government agencies in the United States, Australia, Canada, Saudi Arabia and the United Kingdom. For more information, visit maximus.com.

Statements that are not historical facts, including statements about the Company’s confidence and strategies and the Company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand or acceptance of the Company’s products are forward-looking statements that involve risks and uncertainties. These uncertainties could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements and include reliance on government clients; risks associated with government contracting; risks involved in managing government projects; legislative changes and political developments; opposition from government unions; challenges resulting from growth; adverse publicity; and legal, economic, and other risks detailed in Exhibit 99.1 to the Company’s most recent Annual Report filed with the Securities and Exchange Commission, found on maximus.com.

MAXIMUS
Lisa Miles, 703-251-8637
lisamiles@maximus.com

NEXT ARTICLE

More From BioPortfolio on "MAXIMUS to Present at the Canaccord Genuity Growth Conference August 9"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...